Intuitive Surgical Inc (ISRG) Stock Analysis
Verdict: WATCH (do not buy)
Strong da Vinci 5 ecosystem drives 20%+ earnings growth, but a 47.6x P/E leaves zero buffer for U.S. procedure deceleration.
Investment score: 59/100
Analysis as of
Is Intuitive Surgical Inc stock worth reviewing? AI model thesis
The AI model assigns a WATCH rating to Intuitive Surgical (ISRG). While the firm's zero net debt, 31.3% operating margin, and da Vinci 5 rollout reinforce its moat, an elevated P/E of 47.6x leaves the stock vulnerable to valuation contraction if domestic procedure growth continues to slow.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 90/100 (weight 15%)
- Technical Momentum: 55/100 (weight 15%)
- Earnings Quality: 88/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 68/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Intuitive Surgical Inc opportunities and risks
What speaks for ISRG
- da Vinci 5 and SP platform rollout drives a multi-year capital upgrade cycle
What speaks against ISRG
- Moderating U.S. procedure growth and expiring ACA insurance subsidies compress volume
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ISRG | 47.6x | 13.5x | 32.2x | 66.7% | 28.4% | 2.2% |
| ABT | 32.9x | 3.8x | 18.1x | 56.8% | 11.6% | 4.9% |
| SYK | 29.0x | 4.2x | 17.9x | 65.2% | 14.4% | 4.3% |
| BSX | 17.5x | 3.1x | 13.2x | 71.2% | 17.5% | 5.6% |
| BDX | 56.4x | 2.5x | 15.2x | 46.1% | 4.5% | 5.0% |
| EW | 49.2x | 7.6x | 29.8x | 78.0% | 15.4% | 2.9% |
| Peer median | 32.9x | 3.8x | 17.9x | 65.2% | 14.4% | 4.9% |
Frequently asked questions about Intuitive Surgical Inc (ISRG)
Is ISRG stock a good investment?
The cached TradeMates AI model rates Intuitive Surgical Inc as WATCH (do not buy) with an investment score of 59/100. The AI model assigns a WATCH rating to Intuitive Surgical (ISRG). While the firm's zero net debt, 31.3% operating margin, and da Vinci 5 rollout reinforce its moat, an elevated P/E of 47.6x leaves the stock vulnerable to valuation contraction if domestic procedure growth continues to slow. This is algorithmic model output, not personal investment advice.
Is ISRG stock a buy?
The TradeMates model verdict for ISRG is WATCH (do not buy) with an investment score of 59/100. Treat this as a model signal to review, not a personal buy recommendation.